Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.8260
+0.0010 (0.12%)
Dec 23, 2025, 4:00 PM EST - Market closed
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $20.07 million as of December 23, 2025. Its market cap has decreased by -25.20% in one year.
Market Cap
20.07M
Enterprise Value
2.56M
1-Year Change
-25.20%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from $101.63M to $20.07M, a decrease of -80.26%. That is a compound annual growth rate of -21.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 20.04M | -22.10% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | 121.34M | 39.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |